Overview
Leptospiral rash refers to skin manifestations associated with leptospirosis, an infectious disease caused by pathogenic Leptospira bacteria. These rashes can vary in presentation but often occur alongside systemic symptoms like fever 3.Diagnosis
Clinical History: Travel history, exposure to contaminated water or soil, and recent febrile illness 3.
Physical Examination: Look for characteristic rash patterns, such as hemorrhagic or purpuric lesions, often involving the trunk and extremities 3.
Key Lesions: Presence of non-blanching macules, papules, or urticarial lesions; involvement of palms and soles may be noted 4.
Systemic Symptoms: Fever, myalgia, and conjunctival suffusion can aid in diagnosis 3.
Differential Diagnosis: Rule out other causes of fever and rash, including viral exanthems, drug reactions, and other infectious etiologies 35.
Laboratory Tests: Serological tests (e.g., Microscopic Agglutination Test, MAT), blood cultures, and renal and liver function tests 3.
Imaging and Special Tests: Not typically required unless complications like meningitis or pulmonary involvement are suspected 3.Management
Supportive Care: Fluid resuscitation, management of organ dysfunction, and symptomatic relief 3.
Antibiotics: Penicillin or doxycycline are first-line treatments; duration and specific dosing vary but typically 7-14 days 3.
Adjunctive Therapies: No specific adjunctive therapies are widely recommended beyond supportive care 3.Special Populations
Pediatrics: Fever with rash in children requires careful differentiation from benign viral causes to identify serious illnesses promptly 3.
Comorbidities: Patients with underlying liver or kidney disease may require closer monitoring for organ dysfunction 3.Key Recommendations
Thorough History and Physical Exam to identify risk factors and characteristic rash patterns (Evidence: Moderate 34).
Serological Testing for Leptospira to confirm diagnosis (Evidence: Moderate 3).
Initiate Early Antibiotic Therapy with penicillin or doxycycline for confirmed or highly suspected cases (Evidence: Moderate 3).
Monitor for Systemic Complications especially in pediatric patients and those with comorbidities (Evidence: Expert opinion 3).References
1 Fernandes D, Kwan E, Lenz B. A worsening abdominal rash. The Journal of family practice 2022. link
2 Yu Y, Li J, Zou Y, Yin R. 5-aminolevulinic acid-mediated photodynamic therapy (ALA-PDT) for acneform rash induced by erlotinib: A case report. Photodiagnosis and photodynamic therapy 2022. link
3 Sarkar R, Mishra K, Garg VK. Fever with rash in a child in India. Indian journal of dermatology, venereology and leprology 2012. link
4 Ely JW, Seabury Stone M. The generalized rash: part II. Diagnostic approach. American family physician 2010. link
5 Ely JW, Seabury Stone M. The generalized rash: part I. Differential diagnosis. American family physician 2010. link